Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin and Valsartan in Hypertension and Dyslipidemia
NCT01402843Phase 3Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitavastatin, valsartan in hypertension (HTN), dyslipidemia, sponsored by JW Pharmaceutical Corporation. Started Jun 2011; status: completed.
02
Drugs
pitavastatinvalsartan
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT01402843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402843.